Trade MNOV anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Medicinova Inc (MNOV) is trading at US$1.63, up 0.62% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$68.42M. Over the past 52 weeks, MNOV has traded between US$1.17 and US$1.96. On Syfe you can trade MNOV with $0 commission and add it to your watchlist.
| Previous close | US$1.62 |
|---|---|
| Market cap | US$68.42M |
| 52-week range | US$1.17 – US$1.96 |
| Volume | 96.72K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Medicinova Inc
MediciNova, Inc. is a biopharmaceutical company, which focuses on developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus. Its programs include MN-001, MN-166 neurology diseases, and MN-221 respiratory diseases. The company was founded by Yuichi Iwaki on September 26, 2000 and is headquartered in La Jolla, CA.
Year: 2006
MediciNova Granted US Patent Notice of Allowance for Ibudilast Combination to Treat Brain Cancer
Jun 8, 12:34 PM · MT Newswires
--HC Wainwright Initiates MediciNova at Buy With $10 Price Target
Mar 16, 10:54 AM · MT Newswires
Medicinova Inc (MNOV) stock is trading at US$1.63, +0.62% from the previous close of US$1.62.
The market cap for Medicinova Inc (MNOV) stock is approximately US$68.42M.
The 52-week high for Medicinova Inc (MNOV) stock is US$1.96.
The 52-week low for Medicinova Inc (MNOV) stock is US$1.17.
Medicinova Inc (MNOV) does not currently pay a dividend.
Stay on top of MNOV
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
